UT Southwestern Home

Jun Sasaki, M.D.: Anesthesiology and Pain Management | Pain Management | UT Southwestern Medical Center

https://utswmed.org/doctors/jun-sasaki/

Jun Sasaki, M.D., is in the Division of Anesthesiology And Pain Mgmt at UT Southwestern Medical Center.

Brain Aneurysm Treatments | Brain Aneurysm | UT Southwestern Medical Center

https://utswmed.org/conditions-treatments/brain-aneurysm/brain-aneurysm-treatments/

Neurosurgeons at UT Southwestern are highly experienced in surgical and minimally invasive techniques for treating brain aneurysms.

Brain Aneurysm Risk Factors | Brain Aneurysm | UT Southwestern Medical Center

https://utswmed.org/conditions-treatments/brain-aneurysm/brain-aneurysm-risk-factors/

UT Southwestern neurologists and their teams offer expert guidance to patients with brain aneurysms to help reduce the risk of rupture or stroke.

General Neurology | Peter O'Donnell Jr. Brain Institute | Condition | UT Southwestern Medical Center

https://utswmed.org/conditions-treatments/general-neurology/

UT Southwestern neurologists diagnose and treat patients with a wide range of brain and spine conditions, such as tumors, epilepsy, and Parkinson’s disease.

Seeing the Fire or Measuring the Smoke? Risk Biomarkers of Inflammation | Physician Update 2025 | UT Southwestern Medical Center

https://utswmed.org/heart/physician-update/risk-biomarkers-of-inflammation/

UT Southwestern’s Brittany Weber, M.D., Ph.D., compared biomarker and imaging strategies for inflammation assessment and CVD risk at #AHA25.

CPR Certification vs. Competence: Evaluating Teacher Preparedness in Train-the-Trainer Models | Physician Update 2025 | UT Southwestern Medical Center

https://utswmed.org/heart/physician-update/cpr-cert-vs-competence-trainer-models/

At #AHA25, Drs. Anezi Uzendu and Ameer Cheema of UT Southwestern reported that CPR certification raises teacher confidence but not knowledge.

Efficacy and Safety of Enlicitide, an Oral PCSK9 Inhibitor for Lowering LDL Cholesterol in Adults with or at Risk for ASCVD: The Phase 3 CORALreef Lipids Trial | Physician Update 2025 | UT Southwestern Medical Center

https://utswmed.org/heart/physician-update/efficacy-and-safety-enlicitide-oral-pcsk9-inhibitor/

UT Southwestern’s Ann Marie Navar, M.D., Ph.D., shared #AHA25 results showing oral enlicitide lowers LDL comparably to injectables, offering a new ASCVD option.

Search